USPTO serial 99927413
ROBOTIC TISSUE
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- MASON, JARED MICHAEL
- Law office
- TMO LAW OFFICE 119
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ROBOTIC TISSUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Göttingen, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael Alan Whittaker
162 S. Rancho Santa Fe RoadSuite E70-150Encinitas, CA 92024Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Allogeneic mammalian engineered biological tissue, in particular cultivated tissue with cardiac tissue for treating cardiac insufficiency; biological cultivated cardiac tissue of stem cells for treating cardiac insufficiency; biological cultivated liver tissue intended for subsequent implantation; biological cultivated kidney tissue for medical purposes; biological cultivated brain tissue intended for subsequent implantation; biological cultivated pancreatic tissue intended for subsequent implantation; biological cultivated lung tissue intended for subsequent implantation; biological cultivated muscle tissue intended for subsequent implantation; biological cultivated gastrointestinal tissue intended for subsequent implantation; biological cultivated neuronal tissue intended for subsequent implantation; biological cultivated skin tissue intended for subsequent implantation; biological cultivated bone tissue intended for subsequent implantation; biological cultivated bone marrow intended for subsequent implantation; biological cultivated fat tissue intended for subsequent implantation; biological cultivated connective tissue or biological cultivated blood vessel tissue, all intended for subsequent implantation; Gene therapy products, namely, genetically engineered living tissues for transplant purposes. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 18, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 7, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 7, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2026 | NWAP | NEW APPLICATION ENTERED | — |